152 related articles for article (PubMed ID: 37358701)
1. The evolving landscape of involvement of DTYMK enzymes in cancer.
Heydari N; Mahdizadeh M; Jafari SM
Med Oncol; 2023 Jun; 40(8):213. PubMed ID: 37358701
[TBL] [Abstract][Full Text] [Related]
2. Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer.
Lan T; Wang Y; Miao J; Guo H; Wang Z; Wang J; Zhang C; Yang P; Zhang Z; Dunmall LC; Wang Y
Front Mol Biosci; 2022; 9():887059. PubMed ID: 35903153
[No Abstract] [Full Text] [Related]
3. Differential expression of enzymes in thymidylate biosynthesis in zebrafish at different developmental stages: implications for dtymk mutation-caused neurodegenerative disorders.
Frisk JH; Örn S; Pejler G; Eriksson S; Wang L
BMC Neurosci; 2022 Mar; 23(1):19. PubMed ID: 35346037
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
Zhao H; Xie R; Zhang C; Lu G; Kong H
Front Genet; 2022; 13():989460. PubMed ID: 36159971
[No Abstract] [Full Text] [Related]
5. Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.
Sun F; Liu Y; Gong T; Pan Q; Xiang T; Zhao J; Tang Y; Chen H; Han Y; Song M; Huang Y; Li H; Chen Y; Yang C; Yang J; Wang Q; Li Y; He J; Weng D; Peng R; Xia J
Cell Death Dis; 2021 Nov; 12(12):1093. PubMed ID: 34795209
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
Yu F; Chen Y; Qiu R; Lin N; Yin Y; Zhuo Y; Lin J; Lai F
Physiol Genomics; 2023 May; 55(5):213-221. PubMed ID: 36939206
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.
Liu Y; Marks K; Cowley GS; Carretero J; Liu Q; Nieland TJ; Xu C; Cohoon TJ; Gao P; Zhang Y; Chen Z; Altabef AB; Tchaicha JH; Wang X; Choe S; Driggers EM; Zhang J; Bailey ST; Sharpless NE; Hayes DN; Patel NM; Janne PA; Bardeesy N; Engelman JA; Manning BD; Shaw RJ; Asara JM; Scully R; Kimmelman A; Byers LA; Gibbons DL; Wistuba II; Heymach JV; Kwiatkowski DJ; Kim WY; Kung AL; Gray NS; Root DE; Cantley LC; Wong KK
Cancer Discov; 2013 Aug; 3(8):870-9. PubMed ID: 23715154
[TBL] [Abstract][Full Text] [Related]
8. DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma.
Guo Y; Luo W; Huang S; Zhao W; Chen H; Ma Y; Ye M; Nie Y; Zhang Y; Huang C; Zhou Q; He X; Chen M
J Hepatocell Carcinoma; 2021; 8():871-885. PubMed ID: 34377684
[TBL] [Abstract][Full Text] [Related]
9. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration.
Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z
J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma.
Chen X; Yuan Y; Zhou F; Huang X; Pu J; Niu X; Jiang X; Ding X
Aging (Albany NY); 2022 Sep; 14(19):7866-7876. PubMed ID: 36170019
[TBL] [Abstract][Full Text] [Related]
11. DTYMK is essential for genome integrity and neuronal survival.
Vanoevelen JM; Bierau J; Grashorn JC; Lambrichs E; Kamsteeg EJ; Bok LA; Wevers RA; van der Knaap MS; Bugiani M; Frisk JH; Colnaghi R; O'Driscoll M; Hellebrekers DMEI; Rodenburg R; Ferreira CR; Brunner HG; van den Wijngaard A; Abdel-Salam GMH; Wang L; Stumpel CTRM
Acta Neuropathol; 2022 Feb; 143(2):245-262. PubMed ID: 34918187
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of human thymidylate kinase isoforms.
Hu Frisk J; Pejler G; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2022; 41(3):321-332. PubMed ID: 34994281
[TBL] [Abstract][Full Text] [Related]
13. Deoxythymidylate kinase, DTYMK, is a novel gene for mitochondrial DNA depletion syndrome.
Lam CW; Yeung WL; Ling TK; Wong KC; Law CY
Clin Chim Acta; 2019 Sep; 496():93-99. PubMed ID: 31271740
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
Zhang Y; Wang H; Liu Y; Yang J; Zuo X; Dong M; Zhang Z; Shi Y; Deng X; Lv Y
Biosci Rep; 2022 Oct; 42(10):. PubMed ID: 36094557
[TBL] [Abstract][Full Text] [Related]
15. DTYMK is an essential gene in mice and heterozygosity does not cause neural tube defects.
Tiani KA; Stover PJ
Arch Biochem Biophys; 2024 May; 755():109991. PubMed ID: 38621447
[TBL] [Abstract][Full Text] [Related]
16. DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle.
Zhou T; Qin R; Shi S; Zhang H; Niu C; Ju G; Miao S
Cell Cycle; 2021 Sep; 20(17):1681-1691. PubMed ID: 34369850
[TBL] [Abstract][Full Text] [Related]
17. The Impact of DTYMK as a Prognostic Marker in Colorectal Cancer.
Aloliqi AA; Fararjeh AF; Al-Khader A; Kaddumi E; Eisa AA; Jaradat W
World J Oncol; 2023 Feb; 14(1):84-93. PubMed ID: 36895992
[TBL] [Abstract][Full Text] [Related]
18. High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.
Wang H; Wang X; Xu L; Zhang J; Cao H
Purinergic Signal; 2020 Sep; 16(3):347-366. PubMed ID: 32638267
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase-Akt signaling in pulmonary carcinoid cells.
Pitt SC; Chen H; Kunnimalaiyaan M
J Am Coll Surg; 2009 Jul; 209(1):82-8. PubMed ID: 19651067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
